US StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

60 Degrees Pharmaceuticals Equity Warrants Exp 16 May 2028 Warrant

0.0555

0.0000

Volume:- -

Turnover:45.19

Market Cap:227.80K

PE:- -

High:0.0555

Open:0.0555

Low:0.0555

Close:0.0555

52wk High:0.1560

52wk Low:0.0200

Shares:4.10M

Float Shares:4.10M

Volume Ratio:- -

T/O Rate:- -

Dividend:- -

Dividend Rate:- -

ROE:-127.46%

ROA:-71.91%

PB:-0.06

PE(LYR):- -

Loading ...

Overview Company News Filings

60 Degrees Pharmaceuticals Expands Access to Arakoda® With GoodRx Partnership

THOMSON REUTERS

60 Degrees Pharmaceuticals Announces Partnership With Runway Health to Provide International Travelers Direct Access to Arakoda® for Malaria Prevention

THOMSON REUTERS

BRIEF-60 Degrees Pharmaceuticals, Inc. Announces Approval Of Reverse Stock Split Ratio

60 Degrees Pharmaceuticals Announces Detection of Babesia Infection in 24 Percent of Patients Presenting With Chronic Fatigue in Peer-Reviewed, Sponsored Study at Nc State

THOMSON REUTERS

BRIEF-60 Degrees Pharmaceuticals Announces Expansion Of Arakoda Sales And Marketing In 2026

60 Degrees Pharmaceuticals Inc - to Add Clinical Sites for Babesiosis Trials

THOMSON REUTERS

BRIEF-60 Degrees Pharmaceuticals Announces Clinical Site Now Open For Patient Enrollment

60 Degrees Pharmaceuticals Inc - to Request Type B Meeting With FDA in Early 2026

THOMSON REUTERS

60 Degrees Pharmaceuticals Unveils Name of Chronic Babesiosis Clinical Trial: B-Free Chronic Babesiosis Study

THOMSON REUTERS

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/stock/SXTPW/news"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"SXTPW","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"SXTPW\",,,,,undefined,":{"symbol":"SXTPW","market":"US","secType":"STK","nameCN":"60 Degrees Pharmaceuticals Equity Warrants Exp 16 May 2028 Warrant","latestPrice":0.0555,"timestamp":1771526166292,"preClose":0.0555,"halted":0,"volume":0,"delay":0,"changeRate":0,"floatShares":4104469,"shares":4104469,"eps":0,"marketStatus":"Trading","change":0,"latestTime":"02-19 13:36:06 EST","open":0.0555,"high":0.0555,"low":0.0555,"amount":45.1905488,"amplitude":0,"askPrice":0.069,"askSize":100,"bidPrice":0.0555,"bidSize":400,"shortable":3,"etf":0,"ttmEps":0,"tradingStatus":2,"nextMarketStatus":{"tag":"Post-Mkt","tradingStatus":3,"beginTime":1771534800000},"marketStatusCode":2,"adr":0,"exchange":"NASDAQ","adjPreClose":0.0555,"volumeRatio":0},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"SXTPW\",,,,,undefined,":{"symbol":"SXTPW","floatShares":4104469,"roa":"-71.91%","roe":"-127.46%","lyrEps":0,"shares":4104469,"dividePrice":0,"high":0.0555,"amplitude":0,"preClose":0.0555,"low":0.0555,"week52Low":0.02,"pbRate":"-0.06","psRate":"0.49","week52High":0.156,"institutionHeld":0,"latestPrice":0.0555,"committee":0.6,"eps":0,"divideRate":0,"volume":0,"delay":0,"ttmEps":0,"open":0.0555,"prevYearClose":0.0628,"prevWeekClose":0.0629,"prevMonthClose":0.0572,"prevQuarterClose":0.0628,"fiveDayClose":0.07,"twentyDayClose":0.0598,"sixtyDayClose":0.0494},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/SXTPW\",params:#limit:5,,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"SXTPW\",market:\"US\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"SXTPW\",market:\"US\",delay:false,,,undefined,":{},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"SXTPW\",pageSize:20,pageCount:1,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2608690178","title":"60 Degrees Pharmaceuticals Expands Access to Arakoda® With GoodRx Partnership","url":"https://stock-news.laohu8.com/highlight/detail?id=2608690178","media":"THOMSON REUTERS","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2608690178?lang=en_us&edition=fundamental","pubTime":"2026-02-02 21:01","pubTimestamp":1770037260,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260202:nTUA8D4S5X:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["SXTPW","BK4167","SXTP","GDRX","BK4007"],"gpt_icon":0},{"id":"2605499180","title":"60 Degrees Pharmaceuticals Announces Partnership With Runway Health to Provide International Travelers Direct Access to Arakoda® for Malaria Prevention","url":"https://stock-news.laohu8.com/highlight/detail?id=2605499180","media":"THOMSON REUTERS","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2605499180?lang=en_us&edition=fundamental","pubTime":"2026-01-22 21:01","pubTimestamp":1769086860,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260122:nTUACSMRM:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4007","SXTPW","SXTP"],"gpt_icon":0},{"id":"2603600256","title":"BRIEF-60 Degrees Pharmaceuticals, Inc. Announces Approval Of Reverse Stock Split Ratio","url":"https://stock-news.laohu8.com/highlight/detail?id=2603600256","media":"Reuters","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2603600256?lang=en_us&edition=fundamental","pubTime":"2026-01-15 21:11","pubTimestamp":1768482714,"startTime":"0","endTime":"0","summary":"BRIEF-60 Degrees Pharmaceuticals, Inc. Announces Approval Of Reverse Stock Split RatioJan 15 (Reuters) - 60 Degrees Pharmaceuticals Inc SXTP.O:60 DEGREES PHARMACEUTICALS, INC. ANNOUNCES APPROVAL OF RE","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260115:nTUACXQ3Y:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["SXTPW","SXTP","BK4007"],"gpt_icon":0},{"id":"2595678044","title":"60 Degrees Pharmaceuticals Announces Detection of Babesia Infection in 24 Percent of Patients Presenting With Chronic Fatigue in Peer-Reviewed, Sponsored Study at Nc State","url":"https://stock-news.laohu8.com/highlight/detail?id=2595678044","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2595678044?lang=en_us&edition=fundamental","pubTime":"2025-12-29 21:01","pubTimestamp":1767013260,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251229:nTUA5Z7YHT:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["SXTP","SXTPW","BK4007"],"gpt_icon":0},{"id":"2590516579","title":"BRIEF-60 Degrees Pharmaceuticals Announces Expansion Of Arakoda Sales And Marketing In 2026","url":"https://stock-news.laohu8.com/highlight/detail?id=2590516579","media":"Reuters","labels":["productRelease","express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2590516579?lang=en_us&edition=fundamental","pubTime":"2025-12-11 21:06","pubTimestamp":1765458369,"startTime":"0","endTime":"0","summary":"BRIEF-60 Degrees Pharmaceuticals Announces Expansion Of Arakoda Sales And Marketing In 2026Dec 11 (Reuters) - 60 Degrees Pharmaceuticals Inc SXTP.O:60 DEGREES PHARMACEUTICALS ANNOUNCES EXPANSION OF AR","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251211:nFWN3XH0L9:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease,express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["SXTPW","SXTP","BK4007"],"gpt_icon":0},{"id":"2590515006","title":"60 Degrees Pharmaceuticals Inc - to Add Clinical Sites for Babesiosis Trials","url":"https://stock-news.laohu8.com/highlight/detail?id=2590515006","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2590515006?lang=en_us&edition=fundamental","pubTime":"2025-12-11 21:01","pubTimestamp":1765458071,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251211:nFWN3XH0L9:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["SXTPW","SXTP","BK4007"],"gpt_icon":0},{"id":"2585145552","title":"BRIEF-60 Degrees Pharmaceuticals Announces Clinical Site Now Open For Patient Enrollment","url":"https://stock-news.laohu8.com/highlight/detail?id=2585145552","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2585145552?lang=en_us&edition=fundamental","pubTime":"2025-11-21 21:26","pubTimestamp":1763731611,"startTime":"0","endTime":"0","summary":"BRIEF-60 Degrees Pharmaceuticals Announces Clinical Site Now Open For Patient EnrollmentNov 21 (Reuters) - 60 Degrees Pharmaceuticals Inc SXTP.O:60 DEGREES PHARMACEUTICALS ANNOUNCES CLINICAL SITE NOW ","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251121:nTUA9KLPY7:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["SXTPW","SXTP","BK4007"],"gpt_icon":0},{"id":"2575786636","title":"60 Degrees Pharmaceuticals Inc - to Request Type B Meeting With FDA in Early 2026","url":"https://stock-news.laohu8.com/highlight/detail?id=2575786636","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2575786636?lang=en_us&edition=fundamental","pubTime":"2025-10-15 19:14","pubTimestamp":1760526840,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251015:nTUAW4BXQ:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["SXTP","BK4007","SXTPW"],"gpt_icon":0},{"id":"2574156230","title":"60 Degrees Pharmaceuticals Unveils Name of Chronic Babesiosis Clinical Trial: B-Free Chronic Babesiosis Study","url":"https://stock-news.laohu8.com/highlight/detail?id=2574156230","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2574156230?lang=en_us&edition=fundamental","pubTime":"2025-10-09 19:04","pubTimestamp":1760007840,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251009:nTUA9JBKBQ:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["SXTP","SXTPW","BK4007"],"gpt_icon":0}],"pageSize":20,"totalPage":1,"pageCount":1,"totalSize":9,"code":"91000000","status":"200"}]}}